✦ LIBER ✦

Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma

✍ Scribed by Kuniaki Nakanishi; Toshiaki Kawai; Chikao Torikata; Takashi Aurues; Tomosumi Ikeda

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 328 KB
Volume: 82
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19980215)82:4<724::aid-cncr16>3.0.co;2-#

No coin nor oath required. For personal study only.

✦ Synopsis

involved in tumor invasion and metastasis.

📜 SIMILAR VOLUMES

Expression and cellular localization of

Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma

✍ Dubuisson, L.; Monvoisin, A.; Nielsen, B. S.; Le Bail, B.; Bioulac-Sage, P.; Ros 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

The urokinase-type plasminogen activator (uPA) and its receptor (uPAR) play an important role in tumour invasion. Previous studies have shown by RT-PCR that uPA and uPAR mRNAs are expressed in human hepatocellular carcinoma (HCC). Here, in situ hybridization, immunohistochemistry, and double immuno¯

ELISA for complexes between urokinase-ty

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts

✍ Hans de Witte; Helle Pappot; Nils Brünner; Jan Grøndahl-Hansen; Gunilla Høyer-Ha 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

A sandwich-type ELISA has been developed for the assessment of complexes between urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in extracts of squamous cell lung carcinomas. The assay is based on a combination of rabbit polyclonal anti-uPA antibodies and a biotinylated mouse anti

Elevation of serum levels of urokinase-t

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

✍ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a

Complexes between urokinase-type plasmin

Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assay

✍ Hans De Witte; Fred Sweep; Nils Brünner; Joop Heuvel; Louk Beex; Nicolai Grebens 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 159 KB

Complexes between urokinase-type plasminogen activator (uPA) and its receptor (uPAR) were assessed in plasma and serum from 39 breast cancer patients and from 20 healthy individuals, applying a recently developed enzyme-linked immunosorbent assay (ELISA) for the analysis of these complexes in tumor

Larger and more invasive colorectal carc

Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size

✍ Jinro Abe; Tetsumei Urano; Hiroyuki Konno; Yamaç Erhan; Tatsuo Tanaka; Nobuhiko 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## BACKGROUND. Considering recent findings that both urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitors (PAIs) are involved in tumor growth through an urokinase-type plasminogen activator (uPA) activityindependent mechanism, the relation between the presence of the

Co-expression of urokinase-type plasmino

Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity

✍ Il-Kyoo Park; Bum-Joon Kim; Young-Joo Goh; Mi-Ae Lyu; Chung-Gyu Park; Eung-Soo H 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 205 KB 👁 1 views

The expression of urokinase-type plasminogen activator (u-PA), its receptor (u-PAR) and metalloproteases activity were analyzed in 4 human gastric-cancer cell lines (AGS, Hs746T, SNU-1, and SNU-5), in an attempt to relate these activities to their invasive potential and tumorigenicity on the modifie